Guangdong Jianchi Biotechnology Co., Ltd.
PrivateLast Round
Series C
Jul 1, 2022
Est. Valuation
$148.15M
Total Funding Raised
$14.5M
Company Overview
Guangdong Jianchi Biotechnology Co., Ltd. operates in Healthcare & Life Sciences and is based in Guangzhou. Its latest recorded funding round was a Series C round in July 2022.
Guangdong Jianchi Biotechnology Co., Ltd. is a medical technology company that specializes in the research, development, and manufacturing of dental implants and related oral health medical devices.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical AI, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Guangdong Jianchi Biotechnology Co., Ltd. Comparables
Compare Guangdong Jianchi Biotechnology Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Jiangsu Trausim Medical Instrument Co., Ltd. | 83% | |
| Beijing Datsing Bio-Tech Co., Ltd. | 82% | |
| Gaofeng Medical Equipment (Wuxi) Co., Ltd. | 81% |
For institutional investors. Book with your work email.
Guangdong Jianchi Biotechnology Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Jul 1, 2022 | ||||
| Series B | Jan 22, 2019 |
For institutional investors. Book with your work email.
Guangdong Jianchi Biotechnology Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CSC Group | Series A, Series C |
| Guangxi Investment Group Co., Ltd. | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 1, 2022
Raised $15M with CSC Group and Guangxi Investment Group
- Jan 22, 2019
Completed a Series B funding round.
For institutional investors. Book with your work email.
Guangdong Jianchi Biotechnology Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Guangdong Jianchi Biotechnology Co., Ltd.'s valuation, stock price, and market status.
Is Guangdong Jianchi Biotechnology Co., Ltd. a public or private company?
Guangdong Jianchi Biotechnology Co., Ltd. is a private company.
What is the current stock price of Guangdong Jianchi Biotechnology Co., Ltd.?
Guangdong Jianchi Biotechnology Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks Guangdong Jianchi Biotechnology Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Guangdong Jianchi Biotechnology Co., Ltd. worth (valuation)?
Guangdong Jianchi Biotechnology Co., Ltd.'s valuation is estimated at $148.2M based on funding round data.
Can I buy Guangdong Jianchi Biotechnology Co., Ltd. stock?
Guangdong Jianchi Biotechnology Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Guangdong Jianchi Biotechnology Co., Ltd.'s last funding round?
Guangdong Jianchi Biotechnology Co., Ltd.'s most recent funding round was Series C on July 1, 2022.
Who are the main investors in Guangdong Jianchi Biotechnology Co., Ltd.?
Key investors in Guangdong Jianchi Biotechnology Co., Ltd. include CSC Group, Guangxi Investment Group Co., Ltd..
Will Guangdong Jianchi Biotechnology Co., Ltd. IPO soon?
No public IPO plans have been announced for Guangdong Jianchi Biotechnology Co., Ltd..
How can I track Guangdong Jianchi Biotechnology Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in Guangdong Jianchi Biotechnology Co., Ltd.'s shares on secondary markets.